Biotechnology, Biomedical and Bioinformatics News

Is Canadian Biotech in trouble?

According to Ernst and Young report Beyond Borders: Global Biotechnology Report 2009, the next few years could be troublesome for Canadian Biotechnology Industry.

Rod Budd, Ernst & Young’s Canadian biotech industry leader stated that  “More than half of the Canadian public companies still standing have less than a year’s worth of cash left. The industry must tackle the challenges head-on and evolve the biotech business model to survive in any meaningful way.”

Read more about this report at Ernst & Young website